Infection fatality rate of COVID-19 in community-dwelling elderly populations

This mixed design synthesis aimed to estimate the infection fatality rate (IFR) of Coronavirus Disease 2019 (COVID-19) in community-dwelling elderly populations and other age groups from seroprevalence studies. Protocol: littps://osLio/47cgb. Eligible were seroprevalence studies done in 2020 and identified by any of four existing systematic reviews; with >= 500 participants aged >= 70 years; presenting seroprevalence in elderly people; aimed to generate samples reflecting the general population; and whose location had available data on cumulative COVID-19 deaths in elderly (primary cutoff >= 70 years; >= 65 or >= 60 also eligible). We extracted the most fully adjusted (if unavailable, unadjusted) seroprevalence estimates; age- and residence-stratified cumulative COVID-19 deaths (until 1 week after the seroprevalence sampling midpoint) from official reports; and population statistics, to calculate IFRs adjusted for test performance. Sample size-weighted IFRs were estimated for countries with multiple estimates. Thirteen seroprevalence surveys representing 11 high-income countries were included in the main analysis. Median IFR in community-dwelling elderly and elderly overall was 2.9% (range 1.8-9.7%) and 4.5% (range 2.5-16.7%) without accounting for seroreversion (2.2% and 4.0%, respectively, accounting for 5% monthly seroreversion). Multiple sensitivity analyses yielded similar results. IFR was higher with larger proportions of people >85 years. The IFR of COVID-19 in community-dwelling elderly is lower than previously reported.

Automated summary

This mixed design synthesis estimated the infection fatality rate (IFR) of COVID-19 in community-dwelling elderly populations and other age groups through seroprevalence studies. The results showed that the IFR in community-dwelling elderly was lower than previously reported.